Despite introducing a Substitute Bill much reduced in scope and budget, our bill stalled in the Labor and Commerce Committee on February 21, 2025.
We look forward to picking up our bill next session, refining its scope, meeting with stakeholders, growing our coalition, and continuing to advance legislation for safe psychedelic care.
SB 5201 is scheduled for a public hearing in the Senate Committee for Labor & Commerce on Tuesday, February 18, 2025, at 10:30 AM. Please sign up to testify, submit written testimony, or state your position for the Senate record here:
“We should not force our service members or veterans to go down to Mexico to get this treatment.”— Congressman Dan Crenshaw, R-Texas
“From the opioid crisis to psilocybin’s potential with PTSD, it’s well past time we take drug use out of criminal consideration and into medical consideration.”— Rep. Alexandria Ocasio-Cortez, D-NY
“I try to tell people this isn’t partisan at all. Let’s take our labels away on this one. This is about humankind. This is about taking care of individuals. This is about saving lives. This is about giving people their lives back.”— Former Texas Governor Rick Perry
“We should not force our service members or veterans to go down to Mexico to get this treatment.”
– Congressman Dan Crenshaw, R-Texas
“From the opioid crisis to psilocybin’s potential with PTSD, it’s well past time we take drug use out of criminal consideration and into medical consideration.”
– Rep. Alexandria Ocasio-Cortez, D-NY
“I try to tell people this isn’t partisan at all. Let’s take our labels away on this one. This is about humankind. This is about taking care of individuals. This is about saving lives. This is about giving people their lives back.”
– Former Texas Governor Rick Perry
This bill creates a regulated framework for clinical and supervised access to psilocybin.
This legislation proposes a research study, managed by the University of Washington, to assess the effectiveness of ibogaine-assisted therapy to treat opioid use disorder.
The Food and Drug Administration is set up for approving synthetic drugs—it does not have a well-established pathway for plant-based compounds.
Colorado Governor Jared Polis discussed with Bill Maher why he supports his state’s recent legalization of professional psychedelic services, noting how it is “ridiculous” for the FDA to mandate expensive synthetics instead of whole mushrooms.